Cimzia 2X200 MG/ML(X3)start KTS
Ended Awarded
- Contract number
- SPE2DB25FXAJZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,672
Award facts
- Contract value 100% obligated
- $10,671.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Cimzia 2X200 mg/ml starter kits with a ceiling value of $10,671.73. This firm fixed-price delivery order is non-set-aside and is due for completion by September 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle that extends through December 2026 and enables the company to supply a comprehensive range of pharmaceutical products to support military healthcare programs worldwide.
Cimzia is a biologic immunosuppressant used in the treatment of inflammatory conditions including rheumatoid arthritis, ankylosing spondylitis, and other autoimmune disorders. AmerisourceBergen Drug Corp regularly fulfills federal pharmaceutical procurement requirements through its competitive awards from the DLA, supplying specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This award reflects the company's established capability to meet federal medical supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DB25FXAJZ?
SPE2DB25FXAJZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FXAJZ worth?
The government has obligated $10,672 on SPE2DB25FXAJZ.
Is contract SPE2DB25FXAJZ an order under another contract?
Yes. SPE2DB25FXAJZ is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FXAJZ competed?
The extent of competition for SPE2DB25FXAJZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award